LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/05/2025
Back to search
Official data from USPTO
NEOCELLA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
09/06/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
12/02/2022
Registration date
08/27/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2024
Last transaction
09/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
US
Examiner
SEGAL, MOLLY
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NEOCELLA INC.
Representatives
Kisuk Lee Harness, Dickey & Pierce, PLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Veterinary preparations for oncologycancers; vaccines; non-prescription medicines for oncologycancers; contrast media for in vivo imaging; radioactive pharmaceutical preparations for in vivo diagnostics and therapeutic use; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents in the form of biologicscapsuletablet; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic agents for medical purposes; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; contrast media for use in medical imaging; biological preparations for medical or veterinary purposesfor the treatment of cancer; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; antibodies for medical purposes; Pharmaceutical preparations for oncology and precision medicinecancer; radioisotope markers for therapeutic or diagnostic use
Class 42
Cell separation research services; development of cell therapy products; drug discovery services; research to develop new products in the field of oncology and precision medicinecancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testinginspection and research services in the fields of pharmaceuticalscosmetics and foodstuffs; Pharmaceutical drug development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical drug development services; consultancy pertaining to pharmacology; medicine research; stem cell research services; DNA analysis for scientific research purposes; consultation and providing information in the field of biomedicine research and development; research relating to crude drugs; biochemical analysis; clinical research in the field of medicine; scientific research services for medical purposes
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/13/2025
FIMP
FINAL DISPOSITION PROCESSED
02/13/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/27/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/27/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/17/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/31/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2024
PUBO
PUBLISHED FOR OPPOSITION
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/07/2024
DOCK
ASSIGNED TO EXAMINER
04/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/26/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/26/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/26/2024
RFNT
REFUSAL PROCESSED BY IB
10/25/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/02/2023
RFRR
REFUSAL PROCESSED BY MPU
10/02/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/20/2023
CNRT
NON-FINAL ACTION WRITTEN
09/19/2023
DOCK
ASSIGNED TO EXAMINER
09/12/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/02/2023
Continuous trademark protection
Get notified about every new filing that threatens NEOCELLA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.